Skip to main content
Clinical Trials/IRCT2014091919217N1
IRCT2014091919217N1
Completed
Phase 2

Evaluation of autologous bone marrow stem cells transfusion in treatment of cirrhotic, in decompensated cirrhotic patients

Vice chancellor for research, Mashhad University of Medical Sciences0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cirrhotic of liver.
Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences
Enrollment
20
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age range of 18 to 60 years; Having cirrhosis, based on clinical symptoms and laboratory, endoscopic and radiological findings; Being a candidate for liver transplant. Exclusion criteria: Concurrent diseases such as heart, kidney, and pulmonary conditions; Presence of a hepatic mass indicating hepatocellular carcinoma, according to radiological findings; Extrahepatic malignancies; Moderate to severe hepatic encephalopathy; HIV positive; Presence of malignancies; Activated hepatic vein thrombosis, spleen and portal venous; Concurrent extrahepatic infections; Active venous bleeding; History of alcohol consumption; Lack of patient’s consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials